{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:51:24Z","timestamp":1791456684728,"version":"4.3.4"},"reference-count":54,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Obes"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background\/Objectives<\/jats:title>\n                    <jats:p>Associations between adiponectin and chemerin with the most clinically established lipid parameters for assessing cardiovascular risk - LDL-cholesterol, HDL-cholesterol, and triglycerides\u2014are well documented. Since lipoproteins are heterogeneous with respect to size, density, and chemical composition, the examination of their subclasses could help to elucidate the complex interactions between adipokines and lipid metabolism.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Subjects\/Methods<\/jats:title>\n                    <jats:p>Lipoprotein subclasses were quantified by nuclear magnetic resonance spectroscopy in samples from 3199 participants of the Study of Health in Pomerania (SHIP-TREND-0). Associations between adiponectin\/chemerin and lipoprotein subclasses were analyzed using appropriately adjusted linear regression models.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The analyses revealed a wide range of statistically significant associations between adiponectin\/chemerin and lipoprotein subclasses, that were primarily in opposite directions. Higher adiponectin concentrations were, for example, related to a lower particle number and a lower cholesterol, phospholipid and triglyceride content in atherogenic small, dense LDL-particles, while positive associations were observed for chemerin.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Our highly consistent results demonstrate that high adiponectin was associated with a favorable, anti-atherogenic lipoprotein profile, whereas the opposite was observed for chemerin. Whether these cross-sectional associations reflect causal mechanisms or alternatively, shared underlying metabolic processes, must be clarified by experimental and longitudinal research.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41366-026-02138-8","type":"journal-article","created":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T21:27:36Z","timestamp":1782509256000},"page":"1978-1987","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Linking circulating chemerin and adiponectin to lipoprotein subclasses measured by 1H-NMR spectroscopy in 3199 participants from the study of health in Pomerania"],"prefix":"10.1038","volume":"50","author":[{"given":"Benjamin","family":"Spindler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4420-5449","authenticated-orcid":false,"given":"Anke","family":"Hannemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"V\u00f6lzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gro\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bahls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathrin","family":"Budde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Petersmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Kristin","family":"Henning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Winter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"K\u00f6nemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6678-7964","authenticated-orcid":false,"given":"Matthias","family":"Nauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nele","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Zylla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,26]]},"reference":[{"key":"2138_CR1","unstructured":"NCD Risk Factor Collaboration. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Lancet. 2017;390:2627\u201342."},{"key":"2138_CR2","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1016\/j.tips.2015.04.014","volume":"36","author":"M Fasshauer","year":"2015","unstructured":"Fasshauer M, Bl\u00fcher M. Adipokines in health and disease. Trends Pharmacol Sci. 2015;36:461\u201370.","journal-title":"Trends Pharmacol Sci"},{"key":"2138_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00018-022-04286-2","volume":"79","author":"L Liu","year":"2022","unstructured":"Liu L, Shi Z, Ji X, Zhang W, Luan J, Zahr T, et al. Adipokines, adiposity, and atherosclerosis. Cell Mol Life Sci. 2022;79:1\u201318.","journal-title":"Cell Mol Life Sci"},{"key":"2138_CR4","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1084\/jem.20030382","volume":"198","author":"V Wittamer","year":"2003","unstructured":"Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, et al. Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med. 2003;198:977\u201385.","journal-title":"J Exp Med"},{"key":"2138_CR5","doi-asserted-by":"publisher","first-page":"4542","DOI":"10.1210\/jc.2005-0372","volume":"90","author":"CS Mantzoros","year":"2005","unstructured":"Mantzoros CS, Li T, Manson JE, Meigs JB, Hu FB. Circulating adiponectin levels are associated with better glycemic control, more favorable lipid profile, and reduced inflammation in women with type 2 diabetes. J Clin Endocrinol Metab. 2005;90:4542\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2138_CR6","doi-asserted-by":"publisher","first-page":"2764","DOI":"10.1210\/jcem.87.6.8550","volume":"87","author":"M Matsubara","year":"2002","unstructured":"Matsubara M, Maruoka S, Katayose S. Decreased plasma adiponectin concentrations in women with dyslipidemia. J Clin Endocrinol Metab. 2002;87:2764\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"2138_CR7","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1111\/cen.14441","volume":"94","author":"HH Chou","year":"2021","unstructured":"Chou HH, Teng MS, Hsu LA, Er LK, Wu S, Ko YL. Circulating chemerin level is associated with metabolic, biochemical and haematological parameters-A population-based study. Clin Endocrinol. 2021;94:927\u201339.","journal-title":"Clin Endocrinol"},{"key":"2138_CR8","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1002\/oby.21735","volume":"25","author":"S Zylla","year":"2017","unstructured":"Zylla S, Pietzner M, K\u00fchn JP, V\u00f6lzke H, D\u00f6rr M, Nauck M, et al. Serum chemerin is associated with inflammatory and metabolic parameters-results of a population-based study. Obesity. 2017;25:468\u201375.","journal-title":"Obesity"},{"key":"2138_CR9","doi-asserted-by":"publisher","first-page":"1917","DOI":"10.1001\/jama.1988.03410130125037","volume":"260","author":"MA Austin","year":"1988","unstructured":"Austin MA, Breslow JL, Hennekens CH, Buring JE, Willett WC, Krauss RM. Low-density lipoprotein subclass patterns and risk of myocardial infarction. JAMA. 1988;260:1917\u201321.","journal-title":"JAMA"},{"key":"2138_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphar.2015.00218","volume":"6","author":"A Kontush","year":"2015","unstructured":"Kontush A. HDL particle number and size as predictors of cardiovascular disease. Front Pharmacol. 2015;6:1\u20136.","journal-title":"Front Pharmacol"},{"key":"2138_CR11","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","volume":"71","author":"MV Holmes","year":"2018","unstructured":"Holmes MV, Millwood IY, Kartsonaki C, Hill MR, Bennett DA, Boxall R, et al. Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke. J Am Coll Cardiol. 2018;71:620\u201332.","journal-title":"J Am Coll Cardiol"},{"key":"2138_CR12","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1111\/cen.12363","volume":"81","author":"H L\u0151rincz","year":"2014","unstructured":"L\u0151rincz H, Katk\u00f3 M, Harangi M, Somodi S, Ga\u00e1l K, F\u00fcl\u00f6p P, et al. Strong correlations between circulating chemerin levels and lipoprotein subfractions in nondiabetic obese and nonobese subjects. Clin Endocrinol. 2014;81:370\u20137.","journal-title":"Clin Endocrinol"},{"key":"2138_CR13","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2337\/dc09-0084","volume":"32","author":"R Weiss","year":"2009","unstructured":"Weiss R, Otvos JD, Flyvbjerg A, Miserez AR, Frystyk J, Sinnreich R, et al. Adiponectin and lipoprotein particle size. Diabetes Care. 2009;32:1317\u20139.","journal-title":"Diabetes Care"},{"key":"2138_CR14","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2337\/diabetes.55.01.06.db05-1105","volume":"55","author":"C Lara-Castro","year":"2006","unstructured":"Lara-Castro C, Luo N, Wallace P, Klein RL, Garvey WT. Adiponectin multimeric complexes and the metabolic syndrome trait cluster. Diabetes. 2006;55:249\u201359.","journal-title":"Diabetes"},{"key":"2138_CR15","doi-asserted-by":"publisher","first-page":"770","DOI":"10.1016\/j.numecd.2010.01.014","volume":"21","author":"MJ Shin","year":"2011","unstructured":"Shin MJ, Kim OY. Plasma adiponectin is associated with less atherogenic lipoprotein phenotype. Nutr Metab Cardiovasc Dis. 2011;21:770\u20135.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"2138_CR16","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1016\/j.metabol.2012.05.011","volume":"61","author":"K Tsubakio-Yamamoto","year":"2012","unstructured":"Tsubakio-Yamamoto K, Sugimoto T, Nishida M, Okano R, Monden Y, Kitazume-Taneike R, et al. Serum adiponectin level is correlated with the size of HDL and LDL particles determined by high performance liquid chromatography. Metabolism. 2012;61:1763\u201370.","journal-title":"Metabolism"},{"key":"2138_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2019\/3021785","volume":"2019","author":"S Coimbra","year":"2019","unstructured":"Coimbra S, Reis F, Nunes S, Viana S, Valente MJ, Rocha S, et al. The protective role of adiponectin for lipoproteins in end-stage renal disease patients: relationship with diabetes and body mass index. Oxid Med Cell Longev. 2019;2019:1\u201311.","journal-title":"Oxid Med Cell Longev"},{"key":"2138_CR18","doi-asserted-by":"publisher","first-page":"3989","DOI":"10.1210\/jc.2013-1452","volume":"98","author":"R Goldberg","year":"2013","unstructured":"Goldberg R, Temprosa M, Otvos J, Brunzell J, Marcovina S, Mather K, et al. Lifestyle and metformin treatment favorably influence lipoprotein subfraction distribution in the Diabetes Prevention Program. J Clin Endocrinol Metab. 2013;98:3989\u201398.","journal-title":"J Clin Endocrinol Metab"},{"key":"2138_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms25095050","volume":"25","author":"I Klobu\u010dar","year":"2024","unstructured":"Klobu\u010dar I, Habisch H, Klobu\u010dar L, Trbu\u0161i\u0107 M, Pregartner G, Berghold A, et al. Serum levels of adiponectin are strongly associated with lipoprotein subclasses in healthy volunteers but not in patients with metabolic syndrome. Int J Mol Sci. 2024;25:1\u201317.","journal-title":"Int J Mol Sci"},{"key":"2138_CR20","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1210\/jc.2015-1357","volume":"100","author":"RM Calderon","year":"2015","unstructured":"Calderon RM, Diaz S, Szeto A, Llinas JA, Hughes TA, Mendez AJ, et al. Elevated lipoprotein lipase activity does not account for the association between adiponectin and HDL in Type 1 Diabetes. J Clin Endocrinol Metab. 2015;100:2581\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"2138_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jdiacomp.2021.107856","volume":"35","author":"GD Dias","year":"2021","unstructured":"Dias GD, Cartolano FC, Freitas MCP, Santa-Helena E, Markus MRP, Santos RD, et al. Adiponectin predicts the antioxidant capacity and size of high-density lipoprotein (HDL) in individuals with diabetes mellitus. J Diabetes Complicat. 2021;35:1\u20136.","journal-title":"J Diabetes Complicat"},{"key":"2138_CR22","doi-asserted-by":"publisher","first-page":"672","DOI":"10.5551\/jat.22152","volume":"21","author":"T Miyazaki","year":"2014","unstructured":"Miyazaki T, Hiki M, Shimada K, Kume A, Kiyanagi T, Sumiyoshi K, et al. The high molecular weight adiponectin level is associated with the atherogenic lipoprotein profiles in healthy Japanese males. J Atheroscler Thromb. 2014;21:672\u20139.","journal-title":"J Atheroscler Thromb"},{"key":"2138_CR23","doi-asserted-by":"publisher","first-page":"e372","DOI":"10.1093\/ije\/dyac034","volume":"51","author":"H V\u00f6lzke","year":"2022","unstructured":"V\u00f6lzke H, Sch\u00f6ssow J, Schmidt CO, J\u00fcrgens C, Richter A, Werner A, et al. Cohort profile update: the study of health in Pomerania (SHIP). Int J Epidemiol. 2022;51:e372\u2013e83.","journal-title":"Int J Epidemiol"},{"key":"2138_CR24","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1056\/NEJMoa1114248","volume":"367","author":"LA Inker","year":"2012","unstructured":"Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, et al. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med. 2012;367:20\u20139.","journal-title":"N Engl J Med"},{"key":"2138_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/0167-4838(90)90100-T","volume":"1037","author":"MW Baumstark","year":"1990","unstructured":"Baumstark MW, Kreutz W, Berg A, Frey I, Keul J. Structure of human low-density lipoprotein subfractions, determined by X-ray small-angle scattering. Biochim Biophys Acta. 1990;1037:48\u201357.","journal-title":"Biochim Biophys Acta"},{"key":"2138_CR26","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1161\/ATVBAHA.120.315355","volume":"41","author":"SR El Khoudary","year":"2021","unstructured":"El Khoudary SR, Chen X, Nasr AN, Billheimer J, Brooks MM, McConnell D, et al. HDL (high-density lipoprotein) subclasses, lipid content, and function trajectories across the menopause transition: SWAN-HDL Study. Arterioscler Thromb Vasc Biol. 2021;41:951\u201361.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2138_CR27","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.molmet.2018.05.008","volume":"15","author":"BT Palmisano","year":"2018","unstructured":"Palmisano BT, Zhu L, Eckel RH, Stafford JM. Sex differences in lipid and lipoprotein metabolism. Mol Metab. 2018;15:45\u201355.","journal-title":"Mol Metab"},{"key":"2138_CR28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fphys.2022.931931","volume":"13","author":"YN Qiao","year":"2022","unstructured":"Qiao YN, Zou YL, Guo SD. Low-density lipoprotein particles in atherosclerosis. Front Physiol. 2022;13:1\u201315.","journal-title":"Front Physiol"},{"key":"2138_CR29","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1016\/j.addr.2020.07.019","volume":"159","author":"J Soppert","year":"2020","unstructured":"Soppert J, Lehrke M, Marx N, Jankowski J, Noels H. Lipoproteins and lipids in cardiovascular disease: from mechanistic insights to therapeutic targeting. Adv Drug Deliv Rev. 2020;159:4\u201333.","journal-title":"Adv Drug Deliv Rev"},{"key":"2138_CR30","unstructured":"Feingold KR. Introduction to lipids and lipoproteins [Updated 2024 Jan 14]. In: Feingold KR, Adler RA, Ahmed SF, Anawalt B, Blackman MR, Chrousos G, et al. (eds). Endotext. South Dartmouth (MA). South Dartmouth (MA): MDText.com, Inc.; 2000-. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK305896\/"},{"key":"2138_CR31","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1016\/j.jacc.2020.03.072","volume":"75","author":"M Balling","year":"2020","unstructured":"Balling M, Nordestgaard BG, Langsted A, Varbo A, Kamstrup PR, Afzal S. Small dense low-density lipoprotein cholesterol predicts atherosclerotic cardiovascular disease in the Copenhagen General Population Study. J Am Coll Cardiol. 2020;75:2873\u20135.","journal-title":"J Am Coll Cardiol"},{"key":"2138_CR32","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.atherosclerosis.2007.03.034","volume":"197","author":"M Rizzo","year":"2008","unstructured":"Rizzo M, Pernice V, Frasheri A, Berneis K. Atherogenic lipoprotein phenotype and LDL size and subclasses in patients with peripheral arterial disease. Atherosclerosis. 2008;197:237\u201341.","journal-title":"Atherosclerosis"},{"key":"2138_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms20133151","volume":"20","author":"J Girona","year":"2019","unstructured":"Girona J, Amigo N, Ibarretxe D, Plana N, Rodriguez-Borjabad C, Heras M, et al. HDL triglycerides: a new marker of metabolic and cardiovascular risk. Int J Mol Sci. 2019;20:1\u201310.","journal-title":"Int J Mol Sci"},{"key":"2138_CR34","doi-asserted-by":"publisher","first-page":"4633","DOI":"10.1021\/bi300555d","volume":"51","author":"X Gao","year":"2012","unstructured":"Gao X, Yuan S, Jayaraman S, Gursky O. Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL. Biochemistry. 2012;51:4633\u201341.","journal-title":"Biochemistry"},{"key":"2138_CR35","doi-asserted-by":"crossref","unstructured":"Zimodro JM, Mucha M, Berthold HK, Gouni-Berthold I. Lipoprotein metabolism, dyslipidemia, and lipid-lowering therapy in women: a comprehensive review. Pharmaceuticals. 2024;17:913.","DOI":"10.3390\/ph17070913"},{"key":"2138_CR36","doi-asserted-by":"publisher","first-page":"3419","DOI":"10.1210\/jc.2016-2144","volume":"101","author":"SR El Khoudary","year":"2016","unstructured":"El Khoudary SR, Hutchins PM, Matthews KA, Brooks MM, Orchard TJ, Ronsein GE, et al. Cholesterol efflux capacity and subclasses of HDL particles in healthy women transitioning through menopause. J Clin Endocrinol Metab. 2016;101:3419\u201328.","journal-title":"J Clin Endocrinol Metab"},{"key":"2138_CR37","doi-asserted-by":"publisher","first-page":"2925","DOI":"10.2337\/diacare.27.12.2925","volume":"27","author":"M von Eynatten","year":"2004","unstructured":"von Eynatten M, Schneider JG, Humpert PM, Rudofsky G, Schmidt N, Barosch P, et al. Decreased plasma lipoprotein lipase in hypoadiponectinemia: an association independent of systemic inflammation and insulin resistance. Diabetes Care. 2004;27:2925\u20139.","journal-title":"Diabetes Care"},{"key":"2138_CR38","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.2337\/db07-0435","volume":"57","author":"L Qiao","year":"2008","unstructured":"Qiao L, Zou C, van der Westhuyzen DR, Shao J. Adiponectin reduces plasma triglyceride by increasing VLDL triglyceride catabolism. Diabetes. 2008;57:1824\u201333.","journal-title":"Diabetes"},{"key":"2138_CR39","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1194\/jlr.M300091-JLR200","volume":"44","author":"MC Cheung","year":"2003","unstructured":"Cheung MC, Sibley SD, Palmer JP, Oram JF, Brunzell JD. Lipoprotein lipase and hepatic lipase: their relationship with HDL subspecies Lp(A-I) and Lp(A-I,A-II). J Lipid Res. 2003;44:1552\u20138.","journal-title":"J Lipid Res"},{"key":"2138_CR40","doi-asserted-by":"publisher","first-page":"2005","DOI":"10.1073\/pnas.98.4.2005","volume":"98","author":"J Fruebis","year":"2001","unstructured":"Fruebis J, Tsao TS, Javorschi S, Ebbets-Reed D, Erickson MR, Yen FT, et al. Proteolytic cleavage product of 30-kDa adipocyte complement-related protein increases fatty acid oxidation in muscle and causes weight loss in mice. Proc Natl Acad Sci USA. 2001;98:2005\u201310.","journal-title":"Proc Natl Acad Sci USA"},{"key":"2138_CR41","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1007\/s11154-013-9280-6","volume":"15","author":"TP Combs","year":"2014","unstructured":"Combs TP, Marliss EB. Adiponectin signaling in the liver. Rev Endocr Metab Disord. 2014;15:137\u201347.","journal-title":"Rev Endocr Metab Disord"},{"key":"2138_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms232415627","volume":"23","author":"W Han","year":"2022","unstructured":"Han W, Yang S, Xiao H, Wang M, Ye J, Cao L, et al. Role of adiponectin in cardiovascular diseases related to glucose and lipid metabolism disorders. Int J Mol Sci. 2022;23:1\u201320.","journal-title":"Int J Mol Sci"},{"key":"2138_CR43","doi-asserted-by":"publisher","first-page":"2731","DOI":"10.2337\/db09-0277","volume":"58","author":"H Sell","year":"2009","unstructured":"Sell H, Laurencikiene J, Taube A, Eckardt K, Cramer A, Horrighs A, et al. Chemerin is a novel adipocyte-derived factor inducing insulin resistance in primary human skeletal muscle cells. Diabetes. 2009;58:2731\u201340.","journal-title":"Diabetes"},{"key":"2138_CR44","doi-asserted-by":"publisher","first-page":"28175","DOI":"10.1074\/jbc.M700793200","volume":"282","author":"KB Goralski","year":"2007","unstructured":"Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, et al. Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem. 2007;282:28175\u201388.","journal-title":"J Biol Chem"},{"key":"2138_CR45","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1111\/obr.12646","volume":"19","author":"F Haczeyni","year":"2018","unstructured":"Haczeyni F, Bell-Anderson KS, Farrell GC. Causes and mechanisms of adipocyte enlargement and adipose expansion. Obes Rev. 2018;19:406\u201320.","journal-title":"Obes Rev"},{"key":"2138_CR46","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1381\/096089204323093345","volume":"14","author":"DR Cottam","year":"2004","unstructured":"Cottam DR, Mattar SG, Barinas-Mitchell E, Eid G, Kuller L, Kelley DE, et al. The chronic inflammatory hypothesis for the morbidity associated with morbid obesity: implications and effects of weight loss. Obes Surg. 2004;14:589\u2013600.","journal-title":"Obes Surg"},{"key":"2138_CR47","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1146\/annurev-physiol-021909-135846","volume":"72","author":"JM Olefsky","year":"2010","unstructured":"Olefsky JM, Glass CK. Macrophages, inflammation, and insulin resistance. Annu Rev Physiol. 2010;72:219\u201346.","journal-title":"Annu Rev Physiol"},{"key":"2138_CR48","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1210\/edrv.23.2.0461","volume":"23","author":"GF Lewis","year":"2002","unstructured":"Lewis GF, Carpentier A, Adeli K, Giacca A. Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes. Endocr Rev. 2002;23:201\u201329.","journal-title":"Endocr Rev"},{"key":"2138_CR49","doi-asserted-by":"publisher","first-page":"1811","DOI":"10.1016\/j.clnu.2020.10.034","volume":"40","author":"H Varkaneh Kord","year":"2021","unstructured":"Varkaneh Kord H, GMT HOS, Zand H, Nazary A, Fatahi S, et al. The influence of fasting and energy-restricted diets on leptin and adiponectin levels in humans: a systematic review and meta-analysis. Clin Nutr. 2021;40:1811\u201321.","journal-title":"Clin Nutr"},{"key":"2138_CR50","doi-asserted-by":"publisher","first-page":"1213","DOI":"10.1111\/j.1365-2362.2012.02713.x","volume":"42","author":"S Bauer","year":"2012","unstructured":"Bauer S, Bala M, Kopp A, Eisinger K, Schmid A, Schneider S, et al. Adipocyte chemerin release is induced by insulin without being translated to higher levels in vivo. Eur J Clin Investig. 2012;42:1213\u201320.","journal-title":"Eur J Clin Investig"},{"key":"2138_CR51","doi-asserted-by":"publisher","first-page":"1637","DOI":"10.1016\/j.jacc.2017.08.006","volume":"70","author":"BG Nordestgaard","year":"2017","unstructured":"Nordestgaard BG. A test in context: lipid profile, fasting versus nonfasting. J Am Coll Cardiol. 2017;70:1637\u201346.","journal-title":"J Am Coll Cardiol"},{"key":"2138_CR52","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.atherosclerosis.2016.07.897","volume":"253","author":"P Chrusciel","year":"2016","unstructured":"Chrusciel P, Sahebkar A, Rembek-Wieliczko M, Serban MC, Ursoniu S, Mikhailidis DP, et al. Impact of statin therapy on plasma adiponectin concentrations: a systematic review and meta-analysis of 43 randomized controlled trial arms. Atherosclerosis. 2016;253:194\u2013208.","journal-title":"Atherosclerosis"},{"key":"2138_CR53","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.atherosclerosis.2013.06.026","volume":"230","author":"A Sahebkar","year":"2013","unstructured":"Sahebkar A, Watts GF. Fibrate therapy and circulating adiponectin concentrations: a systematic review and meta-analysis of randomized placebo-controlled trials. Atherosclerosis. 2013;230:110\u201320.","journal-title":"Atherosclerosis"},{"key":"2138_CR54","first-page":"240","volume":"22","author":"A Tuncez","year":"2019","unstructured":"Tuncez A, Altunkeser BB, Ozturk B, Ates MS, Tezcan H, Aydogan C, et al. Comparative effects of atorvastatin 80 mg and rosuvastatin 40 mg on the levels of serum endocan, chemerin, and galectin-3 in patients with acute myocardial infarction. Anatol J Cardiol. 2019;22:240\u20139.","journal-title":"Anatol J Cardiol"}],"container-title":["International Journal of Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02138-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02138-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02138-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T10:03:09Z","timestamp":1791453789000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41366-026-02138-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,26]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["2138"],"URL":"https:\/\/doi.org\/10.1038\/s41366-026-02138-8","relation":{},"ISSN":["0307-0565","1476-5497"],"issn-type":[{"value":"0307-0565","type":"print"},{"value":"1476-5497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,26]]},"assertion":[{"value":"12 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 June 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}